[#DIV28SUPER] Post-Doctoral Fellowships at Virginia Tech

A postdoctoral position is available in Addiction Research Recovery Research Center at the Virginia Tech Carilion Research Institute.  The position will contribute to NIDA, NIAAA, NCI, and NIDDK funded research studies employing behavioral economics and neuro-economic approaches to address addiction or obesity and its treatment using both human laboratory and clinical trial methodologies.  This position will have the opportunity to participate in studies using our International Quit and Recovery Registry, employing neuro-modulatory (TMS) and fMRI technologies.  Applicants should be interested in pursuing a career in addiction or obesity research, be an effective and productive writer, and have research training in clinical, experimental, cognitive psychology or related fields. Applicants must have completed a Ph.D.  Translational research training and career development opportunities are provided as part of this position. The successful candidate will collaborate with a dynamic, productive federally funded, multi-disciplinary team of researchers situated at the foothill of the Appalachian Mountains. Women and minorities are strongly encouraged to apply. Applications will be reviewed on an ongoing basis. The position will be open until filled. Submit a letter of interest and curriculum vitae and referees to Warren K. Bickel, Ph.D.  wkbickel@vtc.vt.edu

Warren K. Bickel, Ph.D. 


Addiction Recovery Research Center, 

Virginia Tech Carilion Research Institute 

Professor of Psychology, Neuroscience,  and Health Sciences, Virginia Tech

Professor of Psychiatry, Virginia Tech Carilion  School of Medicine


Virginia Tech Carilion Research Institute
2 Riverside Circle
Roanoke, VA, 24016

Email: wkbickel@vt.edu
Tel: 540 526 2088

Fax:  540-985-3361 


International Quit & Recovery Website:




[#DIV28SUPER] 2016 Collaborative Perspectives on Addiction - EARLY REGISTRATION AT A REDUCED FEE ENDS TODAY !!!!



The 2016 Collaborative Perspectives on Addiction Meeting will feature presentations from the National Institute on Alcohol Abuse and Alcoholism


Friday March 18 10am-12pm

Free Preconference Workshop

“A Look Inside the Funding Process at NIAAA”

Dr. Anita Bechtholt, Program Director, Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism



Saturday March 19 12:15pm

Networking Lunch

“New Directions at NIAAA”

Dr. George Koob, Director, National Institute on Alcohol Abuse and Alcoholism


Reserve a Room at the Conference Venue | Conference Registration



Saturday March 19th 12:15-1:15pm: Lunch with Dr. George Koob, Director, National Institute on Alcohol Abuse and Alcoholism


Friday March 18th 10am-12pm: Free Preconference Workshop: “A Look Inside the Funding Process at NIAAA” by Dr. Anita Bechtholt, Program Director, Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism

Do you want to know more about how grants get funded at NIAAA? This preconference workshop will be led by NIAAA program staff and is intended to provide grantees with details about how the funding process really works at NIAAA and clarify the role of program staff in that process. The session will consist of a formal presentation by program staff followed by an open ended discussion with grantees. The overall goal is to get everyone’s questions answered. This activity is primarily targeted toward young investigators and trainees, but all are welcome to attend.




[DIV28_ANNOUNCEMENT] Special Issue of Experimental and Clinical Psychopharmacology

Dear Colleagues-

Please consider submitting an article for this special issue. The due date is less than one month away.

Thank you,

Bill Stoops.

Call for Papers: Experimental and Clinical Psychopharmacology


Special Issue for August 2016 on:

50th Anniversary of APA Division 28: The Past, Present and Future of Psychopharmacology and Substance Abuse


Division 28 was formed in 1966 to provide a home within APA for psychologists interested in the behavioral effects of psychoactive or central nervous system drugs and chemicals.  Today, the Division's overarching mission is to encourage the advancement of knowledge on the behavioral effects of psychotropic drugs and toxicants, including (a) disseminating research-based information on psychopharmacology and substance abuse within APA, in educational settings, and to other scientists; (b) encouraging the application of the results of psychopharmacology research to human affairs; and (c) consideration of education and policy issues pertaining to psychopharmacology, behavioral toxicology, and substance abuse. 


During 2016, we will celebrate the 50th anniversary of Division 28. The proposed special issue will highlight the scientific contributions and historical milestones of APA's Division 28 and its members.  We invite manuscripts on the important scientific, clinical and translational contributions of Division 28 members, as well as commentary on the future of psychopharmacology and substance abuse research. In addition, collaborative, research-based manuscripts that disseminate new data about psychotropic drugs and toxicants are especially encouraged. Such papers could include novel research findings about the behavioral pharmacology of emerging drugs of abuse or newly developed compounds in non-human animals or humans (see [a], above). Research-based papers could also present new information on how aspects of psychopharmacology or substance abuse impact human affairs (see [b], above). Scholarly reflections on the notable changes that have occurred in the areas of psychopharmacology and substance abuse, particularly pertaining to education and policy (see [c], above), during the five decades since the Division was founded are also welcome.


Authors may submit primary research reports, review articles or commentaries to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (www.apa.org/pubs/journals/pha/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on the 50th Anniversary of Division 28.  All submissions will undergo our normal peer review. Manuscripts received no later than March 1, 2016 will be considered for inclusion in the special issue. We strongly encourage individuals to contact us in advance with their ideas and ideally a draft title and abstract.


Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, William W. Stoops, PhD, at william.stoops@uky.edu or Stacey C. Sigmon, PhD at stacey.sigmon@uvm.edu.  Correspondence can also be directed to the Editor, Suzette M. Evans, PhD at se18@cumc.columbia.edu.

William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.


[#DIV28M] Candidates needed for Division 28 Member-at-large and President!

Dear Division 28 Members-

It is time to identify our election slate for next year!  We need candidates for a Member-at-Large position and for President.

For the President position, the winning candidate would serve as President in 2018 and only Division 28 Fellows can serve in this role.  For the Member-at-large opening, the winning candidate would serve 2017-19.

Please consider running!  And if you know someone else who would be a great candidate for one of these roles,  encourage that person to run. 

These Division 28 leadership positions offer a fantastic way to contribute to our Division and to our field more broadly. They are great professional and personal experiences as well. 

Please let me know by this coming Monday February 8th!

President, APA Division 28

Stacey Sigmon, Ph.D.
Department of Psychiatry
College of Medicine

University of Vermont
UHC-SATC, Room 1415
1 S. Prospect Street
Burlington, VT 05401
P: (802) 656-9987
F: (802) 656-5793
E: stacey.sigmon@uvm.edu



[#DIV28SUPER] Division 28 Award Winners!

Please join me in congratulating our 2016 Division 28 Award Winners!  We had many excellent candidates nominated in all three categories, and I would like to thank all the nominees and those who nominated them for their participation this year.  Division 28 has an outstanding roster of young scientists doing excellent work.

Now, for the winners.


MED Associates Brady-Schuster Award honors a mid-career or senior scientist (at least 15 years after doctoral degree) who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance abuse.

This year’s winner is John Grabowski, Ph.D. Dr. Grabowski is Professor of Psychiatry at the University of Minnesota.


Young Psychopharmacologist Award honors a young scientist conducting original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology.

This year’s winner is Matthew Kirkpatrick, Ph.D.  Dr. Kirkpatrick is Assistant Professor in the Department of Preventive Medicine at University of Southern California.


Outstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance abuse. 

This year’s winner is Katherine Marks, Ph.D.  Dr. Marks completed her Ph.D. in Experimental Psychology in 2015 at the University of Kentucky, and she is currently a postdoctoral fellow in the Department of Behavioral Science at the University of Kentucky.


Congratulations to all, and we look forward to your presentations in Denver!



Cathy Stanger

Division 28 Awards Chair


Catherine Stanger, Ph.D.

Associate Professor

Department of Psychiatry

Geisel School of Medicine at Dartmouth

46 Centerra Parkway

Suite 300, HB 7255

Lebanon, NH 03766


Phone 603-646-7023

Fax 603-448-5335


[#DIV28SUPER] Secretary of Defense request for APA to reconsider policy to prohibit psychologists in national security interrogations

Forwarded by Ellen Garrison 


[#DIV28SUPER] NIDA Imaging Genetics Webinar Series Starts Thursday, Jan 21 at 12noon Eastern Standard Time, -5hrs GMT

NIDA Imaging Genetics Webinar Series

NIDA is pleased to webcast its weekly series on Imaging Genetics starting January 21, 2016 and ending March 24, 2016.  All webinars start at 12 noon EST, -5hrs GMT  To join see instructions below.  The invited speakers are


Jan 21.  Ahmad Hariri, Functional Neuroimaging Targets for the Genetic Dissection of Substance Abuse Risk

Jan 28. Sarah Medland, Identifying genetic variants associated with human brain structure: work from the ENIGMA consortium

Feb 4.  Jason Stein, Evaluating the overlap between common genetic variants influencing brain structure and neuropsychiatric diseases

Feb 11. Elliot Stein, Imaging genetic insights into nicotine addiction

Feb 18. Kerry Ressler, Neural Mechanisms at the Intersection of Trauma, Fear, Habits and Addiction

Feb 25. David Glahn, A Family-Based Approach to Imaging Genetics of Addiction and Comorbid Mental Illness

Mar 3. Neda Jahanshad, Neuroimaging genetics of the human structural connectome

Mar 10. Hao Yang, Imaging Genetics of Schizophrenia/Psychosis

Mar 17. Barbara Franke, Cognomics: from gene-finding to understanding the biology underlying psychiatric disorders

Mar 24. Anand Mattay, Genetics of Cognitive Aging


Join WebEx meeting

Meeting number: 620 321 515

Meeting password: Nidagenetics1!

Join by phone

1-877-668-4493 Call-in toll-free number (US/Canada)

1-650-479-3208 Call-in toll number (US/Canada)

Access code: 620 321 515

Toll-free calling restrictions

Add this meeting to your calendar. (Cannot add from mobile devices.)

Can't join the meeting? Contact support. (Please contact support if you are using Windows 10)


Please send me an email so I can send a calendar invite as a reminder.  jpollock@mail.nih.gov



The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309